This report describes the anaesthetic management of a women with a term gestation, Von Hippel Lindau disease (VHLD), and a phaeochromocytoma, scheduled for a combined phaeochromocytoma resection and Caesarean section. Von Hippel Lindau disease is characterized by diffuse haemangioblastomas of the central nervous system (CNS) and viscera. It is also (labdtalol 1,0 mg' kg -t et esmolol 0,75 mg" kg -I) 
benign, these tumours can cause serious symptoms secondary to pressure on surrounding structures or haemorrhage. These patients are also at increased risk for phaeochromocytomas and renal cell carcinomas. ~-3
Case report A 35-yr-old G2PoA~ woman with a history of VHLD since age 26 presented at 22 wk gestation for routine obstetrical evaluation. The patient had had three previous surgical resections for occipital, parietal and cervical haemangioblastomas. She had mild dysaethesias on the left side from the chest down.
For the past ten years the patient had been followed in a VHLD clinic for the development of retinoblastomas, renal cell carcinomas, phaeochromocytomas and ganglioblastomas. She was investigated for phaeochromocytomas with yearly urine measurements of catecholemines and their metabolites. The patient was informed that a recent urine screening revealed evidence of a phaeochromocytoma but, at the time, the patient was not aware of her pregnancy. Her urine measurements were as follows: urine normetanephrine 12966 nmol The patient was examined every week in the prenatal clinic by an obstetrician and an endocrinologist for clinical or laboratory evidence of a hypercatecholaminergic state, e.g., evidence of anxiety, diaphoresis, vomiting, headaches, tremulousness, hypertension, palpitations, convulsions, dysrhythmias, dehydration and hyperglycaemia. 4,5 She was admitted at 27~A wk gestation with a diagnosis of hypertension. Blood pressure (BP) on admission was 150/100 mmHg (MAP 116 mmHg) and heart rate was 85 beats, min -I. She was treated with phenoxybenzamine I0 mg po bid. Propranolol 10 mg po bid was added because the patient developed symptomatic tachycardia. The haemodynamic goals were to maintain BP < 140/90 mmHg, without producing symptomatic postural hypotension and to maintain the heart rate < 100 beats, min -~. She was discharged 17 days later on a regimen of phenoxybenzamine 20 mg po qam and 10 mg po qpm, and propranolol 10 mg po qid, which produced acceptable BP and HR control.
The obstetrician and endocrinologist felt it was unsafe for the patient to go into labour because of reports of the development of hypertensive crisis during labour in patients with phaeochromocytomas. 4-7 She was scheduled for Caesarean section (C/S) at 385/7 wk when the lecithin-sphingomyelin ratio (>2.5) indicated fetal maturity.
There were no preoperative systolic BP's > 140 mmHg or heart rates (HR) >100 beats" min -I. Preoperative ECG showed normal sinus rhythm, no ectopy, haemoglobin 90 g-L -I, haematocrit 34%, glucose 4.3 mmol. L -z and the plasma electrolyte concentrations were normal.
Before surgery she received propranolol 20 mg po, ranitidine 50 mg po and sodium citrate 30 ml. The endocrinologist recommended against administration of phenoxybenzamine because of its long half life (greater than 24 hr). s The intraoperative course of a phaeochromocytoma resection is occasionally complicated by severe haemodynamic instability characterized by hypertension as well as hypotension, which characteristically occurs after removal of the catecholamine secreating tumour. 9 It was felt that these haemodynamic fluctuations could be more easily managed with short-acting intravenous agents.
In the operating room, the patient was given oxygen by face mask, placed with a wedge under her right side, and had pulse oximetry, a noninvasive blood pressure cuff, ECG and fetal heart rate monitoring applied. A 16-gauge peripheral/v, a 20-gauge arterial line, and an 8.5 French right internal jugular introducer and a pulmonary artery catheter were placed using sterile technique and local anaesthesia.
During placement of invasive monitoring, the patient's BP did not exceed 160/100 mmHg (mean arterial pressure (MAP) 115 mmHg), and her HR was <80 beats, min-l despite anxiety. Labetalol in increments of 10 and 20 mg (total I00 mg) was titrated to decrease MAP to approximately 100 mmHg during this time.
Before induction of anaesthesia the BP was 140/90 mmHg (MAP 106), HR 80 beats, min -j, PCWP 17 mmHg, PAP 36/24 mmHg, CVP 12 mmHg, CO 7.3 L" min -~, CI 3.7 L. min -~" m 2. Small doses of nitroprusside (NTP) 0.5 ~tg-kg -j were titrated to bring the MAP to 100 mmHg (total 100 ~tg). After pre-oxygenation, anaesthesia was induced with thiopentone 4 mg. kg -j, lidocaine 1 mg. kg -~, bolus doses, of esmolol 30 mg (total 0.75 mg-kg-J). Succinylcholine 1.5 mg" kg -I, was given to facilitate tracheal intubation after which the BP was 190/120 mmHg and the HR 100 beats, min -j. An additional 1 isg" kg -j nitroprusside decreased the blood pressure to preinduction levels. Anaesthesia was maintained with N20 50% in 02 and 0.5% inspired isoflurane until delivery. Induction to delivery time was four minutes, and uterine incision to delivery time was 70 see.
Apgar scores were 7 at one minute and 8 at five minutes. After delivery, the patient was given sufentanil 0.75 ~g. kg -t, midazolam 2 mg, N20 70% in 02, inspired isoflurane of 0.5% and a syntocinon infusion (20 units. L -l 0.9% saline) at 100 ml. hr -I. After the C/ S was completed, the patient was repositioned and prepared for a right lateral flank incision. Anaesthesia was maintained with sufentanil (0.4/~g. kg -R. hr-I), and lowdose isoflurane. Muscle relaxation was maintained with vecuronium.
Vasodilators were required once after induction. A brief infusion of NTP at 0.25 gg. kg -~. min -t was given during the phaeochromocytoma resection to maintain MAP < 120 mmHg. During the combined procedures, the systolic BP was never > 180 mmHg even with adrenal or aortic massage. Vasopressors were not required after resection of the phaeochromocytoma. Blood glucose remained at 7-9 mmol. L -j. Blood loss was estimated at 1200 mi and four liters of Ringer's Lactate were given. The urine output was 300 ml. At the end of surgery (3.5 hr) residual muscle relaxation was reversed and the trachea was extubated. The patient was transferred to the intensive care unit (ICU) with an/v fentanyl infusion at 100 ~tg. kg -~. The postoperative haematocrit was 33% and blood glucose values remained within the normal range. Admission in the ICU was uneventful and she was discharged to the general surgical ward the following morning with a patient-controlled analgesia pump. Both mother and baby had uncomplicated postoperative courses and were discharged home the following week. The pathology report described a well-circumscribed phaeochromocytoma. Unfortunately, the patient developed a renal cell carcinoma one year later which is scheduled for resection.
Discussion
This case presents unique anaesthetic and obstetrical challenges. The patient presented in the second trimester of pregnancy with a phaeochromocytoma, a potentially lifethreatening disease capable of causing malignant hypertension. She had a history of multiple CNS haemangioblastomas and was at risk of having asymptomatic intracranial and spinal lesions. Obstetrical considerations included the optimal timing for phaeochromocytoma resection and C/S and the use of preoperative adrenergic blockade. Anaesthetic considerations included contraindications to regional anaesthesia and the difficulty of optimizing haemodynamic control in a patient with a phaeochromocytoma and possible intracranial mass. Unknown changes in placental perfusion secondary to chronically elevated catecholamine levels and the requirement for intravenous vasodilators with possible adverse fetal effects were also potential problems.
The anaesthetic management of phaeochromocytomas, in particular phaeochromocytomas in pregnancy, is controversial. 4,5:0 Until recently, recommendations for phaeochromocytoma resection in pregnant patients depended on the fetus's gestational age. Phaeochromocytomas detected in the first trimester were resected and the pregnancies terminated. In the second trimester they were resected without termination of the pregnancy and in the third trimester a combined phaeochromocytoma resection and C/S were performed. 4,7 This aggressive approach to early phaeochromocytoma resection was the result of the high maternal (58%) and fetal mortality (56%) in patients in whom the diagnosis was made unexpectedly postpartum. 5 Since the introduction of effective pharmacological adrenergic blockade, the optimal timing for surgery is debatable. It would be ideal to allow the pregnancy to be carried to term if it incurred minimal risk to the mother and fetus. The lack of supporting evidence for the effectiveness of treatment as well as possible iatrogenic effects of long-term treatment have caused some to recommend immediate removal of the tumour with presurgical alpha adrenergic blockade when the diagnosis is made in the first or early second trimester.3 In one survery of phaeochromocytomas in pregnancy, H fetal and maternal mortality were 0 (n = 1) with early tumour excision and delayed C/S in a patient who had received preoperative alpha adrenergic blockade. Fetal loss and maternal mortafity were also 0 (n = 2) when combined term C/S and tumour excision were performed in patients with preoperative adrenergic blockade. Fetal loss was 33% with no maternal mortality (n = 3) with term delivery and delayed tumour excision. (Patients whose tumour could not be localized at the time of C/S had delayed tumour excisions.) Patients received alpha blockade for 84-91 days without any apparent fetal effects. Although the number of patients followed is too small to make conclusive recommendations, if the patient responds to treatment, and if the fetus is doing well, it seems reasonable to consider a combined phaeochromocytoma resection and C/S at term.
It is interesting to note that our patient's BP did not require treatment until 27 wk of gestation and at that time very small doses of phenoxybenzamine were sufficient despite remarkably high levels of circulating catecholamines. This is consistent with the course of phaeochromocytomas in some pregnant women. 6 More than half of the severe symptoms and maternal deaths occur in the postpartum period, within 72 hr of delivery.
Although phaeochromocytomas have been resected using epidural anaesthesia, 9 spinal cord involvement is estimated to occur in 28-100% of VHLD patients. 1.12 The latter figure comes from an autopsy of ten patients who died of complications of VHLD (cerebral bleeds). All ten patients were found to have spinal cord involvement. The lesions are usually asymptomatic, single, and cervicothoracic in origin, although they may involve the lumbosacral cord and cauda equina. 13 They are usually located in the pia or intramedullary cord posteriorly. In half, meningeal varicosities are present. ~4 Haemangioblastomas have also been found in nerve roots and in vertebrae. The intramedullary spinal haemangioblastomas are associated with a syringomyelia in 60-80% of cases, i.|3, 15, 16 The only previous report in the anaesthesia literature describing a C/S in a woman with VHLD successfully used an Ia-L 3 epidural anaesthetic. ~7 The authors stated that they chose an epidural technique because general anaesthesia presented a "theoretical" risk of a hypertensive crisis in a patient with the potential for an asymptomatic CNS haemangioblastoma. They stated that they also avoided a spinal technique because of the possibility of spinal cord haemangioblastomas. We feel that an epidural technique is also contraindicated if spinal anaesthesia is being avoided on grounds of potential spinal cord involvement. There is the possibility of direct injury to the cord or its nerves and vessels by the epidural needle or catheter.
Cerebellar tumours occur in about 60% of patients with VHLD 2 and brain stem tumours in 14-50%. Accessible lesions are removed surgically, zl5 There is a 3-10% recurrence rate after an apparent complete excision. CAT scan and angiograms are the imaging techniques of choice, although they have missed lesions. ~5 We were particularly concerned with the possibility of occult intracerebral lesions in this woman and the risk of a hypertensive-induced cerebrovascular accident.
During line placement we titrated labetalol in anticipation of laryngoscopy, and surgical stimulation, as long as the fetus and the patient's haemodynamic state allowed. We elected to avoide opioids to control hypertension until the baby was delivered, so as not to contribute to fetal depression. Instead, small boluses of nitroprusside and esmolol were used as adjuvant therapy. We wanted to minimize the use of vasoactive agents with long haft lives. Labetalol has the longest half life of the agents (four hours) vs nitroprusside and esmolol (minutes). 8 These medications have been used during pregnancy without significant effects on the fetus. We used two different adrenergic blockers in order to decrease the dose of each. Labetalol in doses of 1.0 mg. kg -1 has been used safely 18 whereas esmolol has been implicated in causing fetal distress in patients with decreased placental perfusion. 19 The haemodynamic goals during induction were based on an attempt to maintain placental blood flow without risking severe hypertension in a patient with the possibility of an intracranial mass. We chose the supranormal MAP based on what is generally recommended in severe preeclamptics as preinduction haemodynamic goals in order to preserve placental blood flow. 2o Although it was unlikely that this patient's placenta had the ischaemic vascular changes characteristic of preeclampsia we considered that her hypertension and chronic elevated catecholamine levels may have caused some changes in placental blood flow and autoregulation. 4 We also wanted to maintain a safety margin of placental perfusion in case she responded precipitously to the antihypertensives.
During the phaeochromocytoma resection inhalational anaesthesia was limited and an opioid, nitrous oxide, and benzodiazepine maintenance was chosen in order to decrease the risk of uterine atony. The use of ergotamines or prostaglandins to treat uterine atony could have precipitated severe hypertension.
In summary, the management of a patient with VHLD for a combined phaeochromocytoma resection and C/ S is presented. The possibility of asymptomatic spinal cord and CNS haemangiomas led us to avoid regional anaesthesia. Reports of hypertensive crisis in parturients with phaeochromocytomas required that we carefully control hypertension. The patient had preoperative antihypertensive therapy with adrenergic blockers. Anaesthetic goals were to maintain aggressive intraoperative blood pressure control with short-acting vasoactive agents and adrenergic blockers, and, if possible, to avoid using large doses of opioids and benzodiazepines (to control hypertension) prior to delivery of the baby. We also avoided high concentrations of inhalational agents after the C/S to avoid contributing to uterine atony.
